Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;13 Suppl 3(Suppl 3):S11.
doi: 10.1186/1471-2458-13-S3-S11. Epub 2013 Sep 17.

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus

Jai K Das, Anjali Tripathi, Anum Ali, Amman Hassan, Chesarahima Dojosoeandy, Zulfiqar A Bhutta

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus

Jai K Das et al. BMC Public Health. 2013.

Abstract

Background: Diarrhea is a leading cause of mortality in children under 5 years along with its long-term impact on growth and cognitive development. Despite advances in the understanding of diarrheal disorders and management strategies, globally nearly 750,000 children die annually as a consequence of diarrhea.

Methods: We conducted a systematic review of the efficacy and effectiveness studies. We used a standardized abstraction and grading format and performed meta-analyses for all outcomes. The estimated effect of cholera, shigella, Enterotoxigenic Escherichia coli (ETEC) and rotavirus vaccines was determined by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.

Results: A total of 24 papers were selected and analyzed for all the four vaccines. Based on the evidence, we propose a 74% mortality reduction in rotavirus specific mortality, 52% reduction in cholera incidence due to their respective vaccines. We did not find sufficient evidence and a suitable outcome to project mortality reductions for cholera, ETEC and shigella in children under 5 years.

Conclusion: Vaccines for rotavirus and cholera have the potential to reduce diarrhea morbidity and mortality burden. But there is no substantial evidence of efficacy for ETEC and shigella vaccines, although several promising vaccine concepts are moving from the development and testing pipeline towards efficacy and Phase 3 trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Search strategy flow chart for Cholera
Figure 2
Figure 2
Search strategy flow chart for Shigella
Figure 3
Figure 3
Search strategy flow chart for ETEC
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161. doi: 10.1016/S0140-6736(12)60560-1. - DOI - PubMed
    1. World Health Organization. Diarrhoeal Diseases (Updated February 2009) Initiative for Vaccine Research (IVR); Accessed from http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index6.html.
    1. Peirano G, Souza FS, Rodrigues DP. Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil. Memorias do Instituto Oswaldo Cruz. 2006;101(3):245–250. doi: 10.1590/S0074-02762006000300003. - DOI - PubMed
    1. Wenneras C, Erling V. Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr. 2004;22(4):370–382. - PubMed
    1. Lucas MES, Deen JL, Von Seidlein L, Wang XY, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Macuamule A. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. New England Journal of Medicine. 2005;352(8):757–767. doi: 10.1056/NEJMoa043323. - DOI - PubMed

Publication types

MeSH terms